Difficult determination of some

important predictive biomarkers (eg increased HER2/neu expression in breast

cancer)

Impossibility to detect complex

relationships of tumor tissue and its immediate surroundings (tumor

microenvironment)

From the patient's perspective,

the need for more burdensome medical intervention

More difficult validation and

standardization of various methodological procedures